Skip to content

ELTGOL and Bronchiectasis. Respiratory Therapy

Multicenter Randomized Placebo-controlled Trial to Evaluate the Efficacy of the ELTGOL Technique in the Drainage of Secretions in Patients With Bronchiectasis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01578681
Acronym
ELTGOLBQ
Enrollment
44
Registered
2012-04-17
Start date
2011-09-30
Completion date
2017-03-31
Last updated
2017-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis, Respiratory; Complications, Therapy

Keywords

bronchiectasis, respiratory therapy, airway clearance

Brief summary

The ELTGOL technique improves mucociliary clearance in adult patients with bronchiectasis. Primary objective: -To evaluate the efficacy of ELTGOL in stable state patients with bronchiectasis compared to placebo. Secondary objectives: * To evaluate the level of knowledge of airway clearance techniques and adherence to them in patients with bronchiectasis. * To assess the side effects during the procedure: oxygen desaturation, increased dyspnea and hemoptysis.

Detailed description

The incidence of bronchiectasis has increased in recent years resulting in greater costs, including periods of hospitalisation and the prescription of drugs. The mucociliary clearance mechanism is impaired in these patients, and chest physiotherapy has been recommended for patients with bronchiectasis and chronic productive cough and/or evidence of mucus plugging on HRCT. However, to date, there is insufficient evidence of benefits of chest physiotherapy through randomised controlled trials. Furthermore it rests unclear the most effective technique, the frequency and optimum duration of the RP and the most suitable variables to monitor. A multicenter clinical trial into the efficacy of one chest physiotherapy technique in airway clearance will fill this important gap in the scientific evidence.

Interventions

PROCEDURELow Expiration Open glottis inferolateral (ELTGOL)

Place the affected lung in infralateral, asks the patient to make an inspiration without being forced to medium volume, and then a slow expiration with the glottis open, down to residual volume. If the therapist is present place the abdominal caudal hand at putting pressure cranial head and hand is placed over the rib cage at a pressure of closing the rib cage. Otherwise, the patient self-administered intertwining arms and abdominal rib at top exerting the same pressure. In case you have two lungs affected the art will take place on one side and then the opposite.

PROCEDUREStretching

Patient will be instructed to do muscle stretching of the thorax

Sponsors

Spanish Clinical Research Network - SCReN
CollaboratorNETWORK
Sociedad Española de Neumología y Cirugía Torácica
CollaboratorOTHER
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* All subjects ≥ 18 years old. * Diagnosis of bronchiectasis using a high-resolution computed tomography (HRCT) chest scan performed in the last 2 years. * Clinically stable disease (defined as no requirement for antibiotics for exacerbation in the 4 weeks preceding study entry. * Chronic sputum expectoration \>10ml/24h.

Exclusion criteria

* Bronchiectasis secondary to cystic fibrosis. * Inability to perform physiotherapy techniques. * Inability to attend the following controls. * Treatment with mucolytics, DNase or hypertonic saline during the study. * Smokers and ex-smokers ≥ 10 pack/year.

Design outcomes

Primary

MeasureTime frameDescription
To evaluate the efficacy of ELTGOL in stable state patients with bronchiectasis compared to placebo1 yearThe primary endpoint for the study is: •Sputum volume during the procedure in the second visit and 24h post treatment which is defined as the volume of mucus expectorated during the physiotherapy procedure and 24h post treatment measured by ml.

Secondary

MeasureTime frameDescription
Side effects, knowledge1 year* To evaluate the level of knowledge of airway clearance techniques and adherence to them in patients with bronchiectasis. * To assess the side effects during the procedure: oxygen desaturation, increased dyspnea and hemoptysis.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026